Abstract
Mucormycosis is considered to be a rare notorious fungal infection mainly affecting diabetics with or withoutketoacidosis & immunocompromised patients, with high mortality rate. Occurrence of Mucormycosis as animplication of Covid-19 has not yet been reported. We present a case of aggressive mucormycosis in a Postcovid-19 type-2 diabetic patient and aim to illustrate the possible Covid-19 effects on body and a dire needfor early diagnosis.
Cite
CITATION STYLE
Pathak, K., Karadwal, A., Nayak, P., & Nayak, S. (2021). Mucormycosis in Post Covid Patient - A Case Report. Indian Journal of Forensic Medicine & Toxicology, 15(3), 240–244. https://doi.org/10.37506/ijfmt.v15i3.15311
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.